André Gernez
André Gernez (born January 25, 1923 in Avesnes-les-Aubert , Département Nord ; † January 8, 2014 in Roubaix , Département Nord) was a French doctor who was best known for his unconventional cancer prevention methods . Many of his theories and methods are not recognized by the scientific community.
Life
After completing his medical degree, Gernez joined the Institut Curie cancer research center in Paris at the age of 22 . Between 1946 and 1949 he did research there and abroad on Plummer-Vinson syndrome . His research stays took him to Great Britain, Sweden, the USA and Canada. During this time, he also developed the idea of treating cancer at an early stage to prevent it from spreading. Between 1950 and 1976 he worked as head of the radiology department in Lille and later founded his own radiology practice in Roubaix . Presumably Gernez began to draft his theories in 1966 after a call from Antoine Lacassagne , the then chairman of the international cancer congress in Seoul. By 1969, Gernez and Delahousse submitted four papers to the Academy of Sciences in Paris on cancer development, but all of them were rejected.
In 1970, Gernez, together with Pierre Delahousse, Jacques Lacaze and others, developed the idea that neurogenesis was completed with birth. However, this theory has not been recognized by the scientific community. Gernez later founded the Association biologique internationale with several other scientists. He also published a theory about the biological necessity of belief, in which he deduced that a person's religious feelings were already genetically determined in the limbic system . In October 1983 he submitted his theory of schizophrenia to the Academy of Sciences in Paris , in which he postulated that humans use two different neural connections to think.
Gernez died on January 8, 2014, at the age of 90, of respiratory failure in Roubaix Hospital .
Theories
In his life, Gernez dealt with various clinical pictures such as cancer , Alzheimer's , cardiovascular diseases, schizophrenia , myopathies and many more.
Carcinogenesis and Prevention
According to Gernez, he developed a method with which 93% of all cancers could be avoided. He assumes that cancer is a disease that begins with a single degenerate cell. The DNA in human cells is constantly attacked by chemical influences, ionizing radiation and other factors. Every cell has numerous protective mechanisms that constantly repair the damaged DNA or trigger cell death if the cell damage becomes too severe. However, damage to the genome accumulates over time, which is why the likelihood of developing cancer increases with age. If the cellular protective mechanisms finally fail , the cell degenerates. It then also no longer reacts to extracellular signals and divides uncontrollably, so that a tumor develops over time.
Gernez assumes that a single degenerate cancer cell will develop around 1000 cancer cells over a period of approx. 3 years. This cell colony is invisible to imaging because it is still very small. In this early stadium, the body can still heal itself. According to Gernez, this time is ideal for therapy and the chances of recovery are very high, as the existing microtumor is still very unstable. If there is no cure, a million cancer cells will have developed after a total of 5 years. From now on, the body's own healing is no longer possible ( point of no return ). In the eighth year after the onset of cancer, one billion cells were created, the tumor now weighs around one gram. This tumor can be diagnosed, but it is already difficult to cure. If the cancer continues to spread ( metastasis ), death follows about a year later. Gernez points out that these developments vary depending on the type of cancer and can be faster or slower.
As a preventive measure, Gernez therefore recommends an annual program that destroys even small cancer colonies and thus prevents them from spreading. The program must therefore be used regularly, as new cells could degenerate every year. It is important to treat the cells at the very early stage when the cancer cells are still very unstable and therefore very sensitive. The selection factor also plays a role. If one assumes that there are around 1000 cancer cells, the chance is not very great that a cell is already extremely resistant. However, the cells continue to mutate and cancer cells in particular tend to have an increased mutation rate , as the normal cellular control mechanisms are already defective. The more cancer cells there are, the greater the chance that some of the cells are already very resistant. This is why modern chemotherapies are not curative at an advanced stage either, since a large part of the cancer cells often die, but the surviving cancer cells are extremely resistant and quickly grow into new cancer foci, which then no longer respond to the drugs used previously.
Gernez prevention program:
- 30 days of fasting a year. A general reduction in calorie intake is important so that the body has lost around 3–5% of its weight in the end. The carbohydrate content of the diet should also be reduced. The diet should be low in cholesterol and red meat should also be avoided. This reduced diet leads to a mild metabolic acidosis which is said to be very damaging to cancer cells. Gernez also uses the Warburg effect as a reason , which is scientifically confirmed.
- Ingestion of food supplements: During the fasting period, the following substances should be taken in addition: vitamins C, E, D, A, the trace elements magnesium, selenium, chromium, cobalt, sulfur, silicon, flavonoids and ASA . These substances are also said to have a damaging effect on cancer cells. Aspirin ensures better blood flow so that hypoxia is avoided. According to Gernez, a lack of oxygen in the cells leads to an increased biochemical fermentation of the sugar, which is beneficial for cancer cells (see Warburg). For this reason, tobacco should not be consumed as it promotes hypoxia.
- After 30 days, certain pharmaceutically active substances should be taken to eliminate the last cancer cells. Gernez recommends taking colchicine for seven days, cortisone for two days, and other antimitotic pharmaceuticals for three days. Colchicine is a potent cytotoxin that the cell division in derogation and the cells attacking sharing straight. However, the effects on the body are very toxic and use as a therapeutic agent is rare. Gernez recommends taking it only under strict medical supervision and advice, as an incorrect dosage can be fatal. Taking it at your own discretion is strictly not recommended!
Gernez recommended this program for everyone between 35 and 70 years of age. From the age of 60, the program is slightly modified.
Awards and honors
- 1979: Hans Adalbert Schweigart Medal
- 2007: Gold medal from the Société d'encouragement au progrès
- 2012: Large gold medal from the Société d'encouragement au progrès
Publications (selection)
- 1970: Loi et règles de la cancellation. Imprimerie Verschave, Roubaix.
- 1972: Le Cancer (with Georges Beau). Presses de la Cité, Paris.
- 1975: Les grands médicaments (with Henri Pradal). Édition du Seuil, Paris.
- 1975: Néo-postulats biologiques et pathogéniques . La Vie claire, Mandres-les-Roses (France) (first edition 1968).
bibliography
- Soline Abbeville: Les Maladies dégénératives - Les Propositions du Docteur André Gernez. Saint-Denis, 2014.
- Pierre Lance: Savants maudits, chercheurs exclus. Paris, 2003.
Web links
- Biography, bibliography and numerous publications (French, English)
- A. Gernez (1975): Néo-postulats biologiques et pathogéniques. (PDF in the Internet Archive, 69 pages, in French.)
Individual evidence
- ↑ Prévention Cancer - Prévention du active cancer. Retrieved March 1, 2019 .
| personal data | |
|---|---|
| SURNAME | Gernez, André |
| BRIEF DESCRIPTION | French doctor |
| DATE OF BIRTH | January 25, 1923 |
| PLACE OF BIRTH | Avesnes-les-Aubert , North department |
| DATE OF DEATH | January 8, 2014 |
| Place of death | Roubaix , North Department |